Short-term exclusive dealing can be unlawful, FTC says
Medtronic misstated the law when it argued a rival medical device manufacturer could not challenge its contracts as anticompetitive because the deals are temporary and non-binding, the Federal Trade Commission has said.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10